Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cl2020 cells (1 trial)
Brain Diseases (Phase 1)
Brain Ischemia (Phase 1)
Hypoxia (Phase 1)
Hypoxia-Ischemia, Brain (Phase 1)
Ischemia (Phase 1)
Trials (1 total)
Trial APIs (1 total)